Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.

Bhat, M; Hassanain, M; Simoneau, E; Tzimas, G N; Chaudhury, P; Deschenes, M; Valenti, D; Ghali, P; Wong, P; Cabrera, T; Barkun, J; Tchervenkov, J I; Metrakos, P

Bhat, M; Hassanain, M; Simoneau, E; Tzimas, G N; Chaudhury, P; Deschenes, M; Valenti, D; Ghali, P; Wong, P; Cabrera, T; Barkun, J; Tchervenkov, J I; Metrakos, P.

Afiliação

Bhat M; Department of Medicine, Division of Gastroenterology and Hepatology, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC.

Curr Oncol ; 20(5): 265-72, 2013 Oct.

Article em En | MEDLINE | ID: mdl-24155631

Palavras-chave

Hepatocellular carcinoma; alpha-fetoprotein; liver transplantation; transarterial chemoembolization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google